News >

CAR-T Progress Continues in Non-Hodgkin Lymphoma, But Guidelines Need Updating

Ellie Leick
Published: Tuesday, Dec 03, 2019

Miguel Perales, MD

Miguel Perales, MD
CAR T-cell therapy has emerged as a promising therapy for select patients with non-Hodgkin lymphoma (NHL), but as research continues and the treatment is used in a real-world setting, overarching guidelines must be set in place, explained Miguel-Angel Perales, MD.

“The results of CAR T cells in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma are very promising,” said Perales. “We'll have to see what the role of CAR T cells is for these diseases, but it's definitely a therapy that's very effective.”
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication